Overall neoplasms

Disease1 paper1 finding

Associations

1

Semaglutide

upin humans1OR 1.19High certainty

1 study

Semaglutide raises the risk of overall neoplasms in humans (OR 1.19, 95% CI 1.07–1.32).
Reviewtype 2 diabetes26 to 156 weeks
Risk of neoplasms with semaglutide in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials · Frontiers in pharmacology · 3 Sep 2026

Semaglutide →

Latest

1

Frontiers in PharmacologyReview18 Sep

Risk of neoplasms with semaglutide in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials